How does colchicine use affect neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte ratios in coronary artery disease?
Dicle Tıp Dergisi · 05.06.2026 · 53 (2) · 431-441
DOI: 10.5798/dicletip.1964621 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dicle Tıp Dergisi, online erschienen am 05.06.2026. Verfasst von Fatih Öztürk und 1 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objective
It is an established medical fact that the reduction of inflammation plays a pivotal role in the development of atherosclerosis. This reduction of inflammation is an accepted treatment strategy for coronary artery disease (CAD). The objective of the present study was to demonstrate the effect of colchicine, a commonly used anti-inflammatory agent, on inflammatory markers.
Method
The study comprised a sample of 122 patients diagnosed with CAD, whose medical records were meticulously reviewed. Ratios of neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte were calculated and recorded. Following a period of six months during which colchicine was administered, a recalculation of the values was performed.
Results
Prior to the commencement of treatment, the neutrophil/lymphocyte ratio (NLR) (3.99 ± 4.72), monocyte/lymphocyte ratio (MLR) (0.41 ± 0.42), and platelet/lymphocyte ratio (PLR) (129.6 ± 74.1) were observed. Following treatment, a decrease was observed in the neutrophil-to-lymphocyte ratio (NLR) (3.5 ± 3), MLR (0.38 ± 0.28), and PLR (122.6 ± 65). In the post-treatment period, statistically significant decreases were observed NLR, MLR, and PLR compared to pre-treatment levels (p
Zitieren
APA
Öztürk, F., & Yaman, M. (2026). How does colchicine use affect neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte ratios in coronary artery disease?. Dicle Tıp Dergisi, 53(2), 431-441. https://doi.org/10.5798/dicletip.1964621
Vancouver
Öztürk F, Yaman M. How does colchicine use affect neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte ratios in coronary artery disease?. Dicle Tıp Dergisi. 2026;53(2):431-441. doi:10.5798/dicletip.1964621
BibTeX
@article{ztrk2026,
author = {Öztürk, Fatih and Yaman, Mehmet},
title = {How does colchicine use affect neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte ratios in coronary artery disease?},
journal = {Dicle Tıp Dergisi},
year = {2026},
volume = {53},
number = {2},
pages = {431--441},
doi = {10.5798/dicletip.1964621}
}
EUVIMED